HajraITilyMD
Rheumatology • Modesto, CARheumatoid Arthritis & Related, Spondyloarthropathy, Vasculitis
Physician
Dr. Tily is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Coffee Rd
Modesto, CA 95355Phone+1 209-521-6097
Summary
- Dr. Hajra Tily is a rheumatologist in Modesto, CA and is affiliated with Memorial Medical Center. She received her medical degree from Dow University of Health Sciences and has been in practice 16 years. She specializes in rheumatoid arthritis & related, spondyloarthropathy, and vasculitis and is experienced in systemic lupus erythematosus, sjogren's syndrome, crest syndrome, vasculitides, and raynaud's phenomenon.
Education & Training
SUNY Upstate Medical UniversityFellowship, Rheumatology, 2007 - 2009
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 2004 - 2007
Dow University of Health SciencesClass of 2001
Certifications & Licensure
CA State Medical License 2007 - 2026- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 113 citationsMechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus ErythematosusZhi-Wei Lai, Rebecca Borsuk, Ashwini Shadakshari, Jianghong Yu, Maha Dawood
Journal of Immunology. 2013-09-01 - 278 citationsSirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2...Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari
Lancet. 2018-03-24 - 290 citationsN-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, ...Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany Caza, Brandon Clair
Arthritis and Rheumatism. 2012-09-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
